Edwards Lifesciences
692 hedge funds and large institutions have $18.1B invested in Edwards Lifesciences in 2016 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 263 increasing their positions, 253 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 657 → 692 (+35)
4% more repeat investments, than reductions
Existing positions increased: 263 | Existing positions reduced: 253
4.21% less ownership
Funds ownership: 260.73% → 256.52% (-4.2%)
Holders
692
Holding in Top 10
23
Calls
$148M
Puts
$115M
Top Buyers
1 | +$163M | |
2 | +$106M | |
3 | +$99.2M | |
4 |
HM
HealthCor Management
New York
|
+$67.3M |
5 |
American Century Companies
Kansas City,
Missouri
|
+$64.4M |
Top Sellers
1 | -$456M | |
2 | -$227M | |
3 | -$217M | |
4 |
Citadel Advisors
Miami,
Florida
|
-$94M |
5 |
Capital Research Global Investors
Los Angeles,
California
|
-$86.1M |